NS
MDGL icon

NBC Securities’s Madrigal Pharmaceuticals MDGL Stock Holding History

NBC Securities’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8K Hold
48
– – ﹤0.01% 1545
2026
Q1 		$25.1K Hold
48
– – ﹤0.01% 1616
2025
Q4 		$28K Hold
48
– – ﹤0.01% 1614
2025
Q3 		$22K Hold
48
– – ﹤0.01% 1705
2025
Q2 		$14K Hold
48
– – ﹤0.01% 1852
2025
Q1 		$15K Buy
+48
New +$15.8K ﹤0.01% 1602
2024
Q4 		– Sell
-48
Closed -$10K – 1750
2024
Q3 		$10K Hold
48
– – ﹤0.01% 1733
2024
Q2 		$13K Hold
48
– – ﹤0.01% 1596
2024
Q1 		$12K Hold
48
– – ﹤0.01% 1634
2023
Q4 		$11K Hold
48
– – ﹤0.01% 1673
2023
Q3 		$7K Buy
+48
New +$9.04K ﹤0.01% 1798

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NBC Securities's MDGL Position: Q2 2026 in Review

NBC Securities held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 48 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

NBC Securities first reported a position in MDGL in Q3 2023 and has held it in 11 quarters since. The position peaked at $28K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • NBC Securities held 48 shares of Madrigal Pharmaceuticals worth $25.8K as of Q2 2026.
  • NBC Securities left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1545 holding.
  • NBC Securities first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Madrigal Pharmaceuticals position peaked at $28K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.